Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline
Using AUA Guidelines
This AUA guideline is provided free for clinical use only. Anyone accessing AUA guidelines for any other use must obtain permission in advance. Licenses for academic and research purposes can be obtained through the Copyright Clearance Center Marketplace.
Licenses for promotional or commercial use can be obtained by contacting Keith Price at kprice@AUAnet.org.
Access FAQs on usage and licensing of AUA clinical guidelines.
By reading this guideline, you agree to AUA's Terms and Conditions. Read More.
Guideline Resources
BPH Algorithm
BPH Admendment Summary
Benign Prostatic Hyperplasia (BPH) PDF
Summary
Benign prostatic hyperplasia (BPH) is a histologic diagnosis that refers to the proliferation of smooth muscle and epithelial cells within the prostatic transition zone. The prevalence and the severity of lower urinary tract symptoms (LUTS) in the aging male can be progressive and is an important diagnosis in the healthcare of patients and the welfare of society. In the management of bothersome LUTS, it is important that healthcare providers recognize the complex dynamics of the bladder, bladder neck, prostate, and urethra. Further, symptoms may result from interactions of these organs as well as with the central nervous system or other systemic diseases (e.g., metabolic syndrome, congestive heart failure). Despite the more prevalent (and generally first line) use of medical therapy for men suffering from LUTS attributed to BPH (LUTS/BPH), there remain clinical scenarios where surgery is indicated as the initial intervention for LUTS/BPH and should be recommended, providing other medical comorbidities do not preclude this approach. It is the hope that this revised Guideline will provide a useful reference on the effective evidence-based management of male LUTS/BPH. Please see the accompanying algorithm for a summary of the procedures detailed in the Guideline.
Key Takeaways
Lorem ipsum dolor sit amet consectetur adipiscing elit. Quisque faucibus ex sapien vitae pellentesque sem placerat. In id cursus mi pretium tellus duis convallis. Tempus leo eu aenean sed diam urna tempor. Pulvinar vivamus fringilla lacus nec metus bibendum egestas. Iaculis massa nisl malesuada lacinia integer nunc posuere. Ut hendrerit semper vel class aptent taciti sociosqu. Ad litora torquent per conubia nostra inceptos himenaeos.
Lorem ipsum dolor sit amet consectetur adipiscing elit. Quisque faucibus ex sapien vitae pellentesque sem placerat. In id cursus mi pretium tellus duis convallis. Tempus leo eu aenean sed diam urna tempor. Pulvinar vivamus fringilla lacus nec metus bibendum egestas. Iaculis massa nisl malesuada lacinia integer nunc posuere. Ut hendrerit semper vel class aptent taciti sociosqu. Ad litora torquent per conubia nostra inceptos himenaeos.
Create a free account to access expanded content and resources.
The AUA clinical guidelines and clinical statements are developed and peer reviewed by experts based on the lastes evidence-based research available.
Learn about AUA clinical guidelines
Learn about AUA consensus statements.
| Free Resources | |
 |
Free Patient Materials |
 |
Podcast: The Surgical Management of BPH |
 |
Webcast: The Surgical Management of BPH |
| Login Required | |
|
BPH Algorithm |
|
BPH Admendment Summary |
| Member Benefit | |
|
Benign Prostatic Hyperplasia (BPH) PDF |